MIRUM PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.87 USD | -3.72% |
|
-4.06% | -16.02% |
| 07:24pm | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
| May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -3.99% | -4.06% | -16.02% | -5.38% | - | 1.22B |  |  | |
- Stock Market
- Equities
- MIRM Stock
- Charts Mirum Pharmaceuticals, Inc.
- Relative Strength Chart